Research Article
In Vivo Investigation of ALBO-OS Scaffold Based on Hydroxyapatite and PLGA
Table 5
Immunological response 12 weeks after implantation of ALBO-OS and Bio-Oss.
| Immune cells | Number of cells per HPM | Percentage of defects | value ALBO-OS/Bio-Oss | ALBO-OS | Bio-Oss | Empty defect |
| Macrophages | No | 70 | 21.4 | 0 | 0.002 | 1–5 | 30 | 50 | 20 | 5–10 | 0 | 28.6 | 80 |
| Giant cells | No | 70 | 14.3 | 10 | <0.001 | 1–5 | 30 | 57.1 | 20 | 5–10 | 0 | 28.6 | 70 |
| Lymphocytes | No | 75 | 64.3 | 40 | 0.257 | 1–5 | 25 | 21.4 | 60 | 5–10 | 0 | 14.3 | 0 |
| Plasma cells | No | 75 | 71.4 | 40 | 0.746 | 1–5 | 25 | 21.4 | 60 | 5–10 | 0 | 7.1 | 0 |
| Basophils | No | 75 | 71.4 | 50 | 0.562 | 1–5 | 25 | 14.3 | 50 | 5–10 | 0 | 14.3 | 0 |
|
|